Myomo, Inc. (MYO)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Paul R. Gudonis | Chairman, President & CEO | 526.56k | -- | 1955 |
Mr. David A. Henry | Chief Financial Officer | 401.56k | -- | 1961 |
Dr. Harry Kovelman M.D. | Chief Medical Officer | 426.03k | -- | 1959 |
Colin Anderson | Global Director of Operations | -- | -- | -- |
Mr. Joseph Chicoskie | Director of Marketing | -- | -- | -- |
Ms. Galina Shtivelman | Senior Director of Human Resources | -- | -- | -- |
Mr. Micah J. Mitchell | Chief Commercial Officer | 317.39k | -- | 1976 |
Myomo, Inc.
- Sector:?
- Healthcare
- Industry:? Medical Devices
- Full Time Employees:?
- 101
Description
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Corporate Governance
Upcoming Events
November 5, 2024 at 10:59 AM UTC - November 11, 2024 at 12:00 PM UTC
Myomo, Inc. Earnings Date
Recent Events
August 26, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
May 30, 2024 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)